IRCT20220430054708N1 IRCT 2022-05-31 Esfahan University of Medical Sciences study of the effect of drug treatment (OCP and Methergine) in patients with pregnancy remnants Comparative study of drug treatment outcomes (OCP and Methergine) in aborted patients with pregnancy remnants 2022-06-14 anticipated 80 Complete https://irct.ir/trial/63340 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple random method. 80 cards are selected and numbers from 1-80 are inserted on the cards. The cards are placed in an envelope. Two of the design partners take one card out of the envelope each time and announce the card number. Paired numbers are assigned to the intervention group and odd numbers to the control group, Blinding description: Participants will consciously participate in the study but OCP and methergine will label as A and B. Participants will not know whether the drug is A or B. 2-3 Placental remnants. Intervention 1: The first intervention group will receive OCP (0.03 mg Ethinylestradiol and 0.15 Desogestrel) daily for 21 days. In addition, 100 mg oral Doxycycline capsules every 12 hours for 10 days will be administered. Intervention 2: The second intervention group, patients will receive three times a day (0.25 mg oral Methergine) for 10 days. In addition, 100 mg oral Doxycycline capsules every 12 hours for 10 days will be administered. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information